As per the National Vector Borne Disease Control Programme, the first-line agent for treatment of Kala-azar (visceral leishmaniasis) is:
Amphotericin B, liposomal, IV, single dose
Under India's Kala-azar Elimination Programme (NVBDCP), single-dose liposomal Amphotericin B (approximately 5 mg/kg IV) has replaced the older prolonged regimens (sodium stibogluconate, conventional amphotericin B deoxycholate) as the first-line therapy due to its high efficacy, safety, and short duration.
Similar Questions
Which one of the following illnesses is not covered under the Rashtriya Bal Swasthya Karyakram?
Important Questions from National Child Health Programmes
- Which one of the following vaccines is NOT included in Mission Indradhanush?
According to the 'Integrated Management of Neonatal and Childhood Illnesses' (IMNCI) classification of young infants upto 2 months, which one of the following signs is NOT included in 'Possible Serious Bacterial Infection'
- Neonatal tetanus elimination in India is defined as less than one case per:
Which one of the following facilities has been established at district hospitals in India to strengthen the care of low birth weight babies and sick newborns?
The specific goals for 2025 under the integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD) are all of the following EXCEPT:
